Transitional Care Program vs Standard of Care in Cirrhosis With Volume Overload: A Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital. The main question\[s\] it aims to answer are: * How much time and what resources are needed to run such a program * How well do patients follow up with the phone calls, bloodwork, and doctor appointments? * Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program? Participants will * Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital * Receive a phone call from the study team within 72 hours of discharge and weekly * Be given a follow up appointment with hepatology within 4 weeks of discharge Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients \> 18 years of age.

• Inpatient at Penn State Health, Milton S. Hershey Medical Center.

• Diagnosis of cirrhosis.

• Hospitalized with fluid overload (ascites and/or significant anasarca/edema) requiring diuretic therapy.

• English speaking

Locations
United States
Pennsylvania
Penn State Milton S. Hershey Medical Center
RECRUITING
Hershey
Contact Information
Primary
Karen L Krok, MD
kkrok@pennstatehealth.psu.edu
7175311017
Backup
Shannon F Dalessio
sdalessio@pennstatehealth.psu.edu
7175310003
Time Frame
Start Date: 2025-02-15
Estimated Completion Date: 2026-06-01
Participants
Target number of participants: 20
Treatments
Experimental: Transitional Care Program
Participants will receive a digital scale and monitoring log, educational material, a phone call within 72 hours of discharge and weekly for 8 weeks, and a follow up appointment with a hepatologist within 4 weeks of discharge.
No_intervention: Standard of Care
Participants will be given typical discharge and follow up instructions.
Related Therapeutic Areas
Sponsors
Leads: Milton S. Hershey Medical Center

This content was sourced from clinicaltrials.gov